BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32668257)

  • 21. Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells.
    Chatterjee B; Smed-Sörensen A; Cohn L; Chalouni C; Vandlen R; Lee BC; Widger J; Keler T; Delamarre L; Mellman I
    Blood; 2012 Sep; 120(10):2011-20. PubMed ID: 22791285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation.
    Zehner M; Chasan AI; Schuette V; Embgenbroich M; Quast T; Kolanus W; Burgdorf S
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9933-8. PubMed ID: 21628571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens.
    Gao J; Ochyl LJ; Yang E; Moon JJ
    Int J Nanomedicine; 2017; 12():1251-1264. PubMed ID: 28243087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
    Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aquaporin-3 regulates endosome-to-cytosol transfer via lipid peroxidation for cross presentation.
    Nalle SC; Barreira da Silva R; Zhang H; Decker M; Chalouni C; Xu M; Posthuma G; de Mazière A; Klumperman J; Baz Morelli A; Fleire SJ; Verkman AS; Trombetta ES; Albert ML; Mellman I
    PLoS One; 2020; 15(11):e0238484. PubMed ID: 33232321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UNC93B1 interacts with the calcium sensor STIM1 for efficient antigen cross-presentation in dendritic cells.
    Maschalidi S; Nunes-Hasler P; Nascimento CR; Sallent I; Lannoy V; Garfa-Traore M; Cagnard N; Sepulveda FE; Vargas P; Lennon-Duménil AM; van Endert P; Capiod T; Demaurex N; Darrasse-Jèze G; Manoury B
    Nat Commun; 2017 Nov; 8(1):1640. PubMed ID: 29158474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat shock protein magic in antigen trafficking within dendritic cells: implications in antigen cross-presentation in immunity.
    Udono H
    Acta Med Okayama; 2012; 66(1):1-6. PubMed ID: 22358133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection-mimicking poly(γ-glutamic acid) as adjuvant material for effective anti-tumor immune response.
    Seth A; Heo MB; Sung MH; Lim YT
    Int J Biol Macromol; 2015 Apr; 75():495-504. PubMed ID: 25709015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct antigen uptake receptors route to the same storage compartments for cross-presentation in dendritic cells.
    Ho NI; Camps MG; Garcia-Vallejo JJ; Bos E; Koster AJ; Verdoes M; van Kooyk Y; Ossendorp F
    Immunology; 2021 Nov; 164(3):494-506. PubMed ID: 34110622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.
    Hunzeker JT; Elftman MD; Mellinger JC; Princiotta MF; Bonneau RH; Truckenmiller ME; Norbury CC
    J Immunol; 2011 Jan; 186(1):183-94. PubMed ID: 21098225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are ERAD components involved in cross-presentation?
    Grotzke JE; Cresswell P
    Mol Immunol; 2015 Dec; 68(2 Pt A):112-5. PubMed ID: 26005101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar immune responses and antitumor effects of murine dendritic cells loaded with either exogenous or endogenous-synthesized protein.
    Lacave R; Masurier C; Guigon M; Lemoine FM; Klatzmann D; Colombo BM
    Int J Oncol; 2003 Dec; 23(6):1747-53. PubMed ID: 14612950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer.
    Ugolini A; Tyurin VA; Tyurina YY; Tcyganov EN; Donthireddy L; Kagan VE; Gabrilovich DI; Veglia F
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32584791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
    Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
    J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells.
    Basha G; Lizée G; Reinicke AT; Seipp RP; Omilusik KD; Jefferies WA
    PLoS One; 2008 Sep; 3(9):e3247. PubMed ID: 18802471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy.
    Suzuki R; Oda Y; Utoguchi N; Namai E; Taira Y; Okada N; Kadowaki N; Kodama T; Tachibana K; Maruyama K
    J Control Release; 2009 Feb; 133(3):198-205. PubMed ID: 19000727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased translocation of antigens to endosomes and TLR4 mediated endosomal recruitment of TAP contribute to nicotine augmented cross-presentation.
    Wang YY; Hu ChF; Li J; You X; Gao FG
    Oncotarget; 2016 Jun; 7(25):38451-38466. PubMed ID: 27224911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.
    Liang X; Fu C; Cui W; Ober-Blöbaum JL; Zahner SP; Shrikant PA; Clausen BE; Flavell RA; Mellman I; Jiang A
    J Leukoc Biol; 2014 Jan; 95(1):179-90. PubMed ID: 24023259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity.
    Alloatti A; Rookhuizen DC; Joannas L; Carpier JM; Iborra S; Magalhaes JG; Yatim N; Kozik P; Sancho D; Albert ML; Amigorena S
    J Exp Med; 2017 Aug; 214(8):2231-2241. PubMed ID: 28663435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.